US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Vita Life Sciences Limited (VLS) 銘柄情報

Vita Life Sciences Limited (VLS)

2.45

0.05

(2.08%)

終了 6月5日 3:00PM

Vita Life Sciences Limited (VLS) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.45

( 2.08% )

買値

2.38

売値

2.45

出来高

188

2.45 日の範囲 2.45

1.88 52 週間の範囲 2.84

時価総額

前日終値

2.40

始値

2.45

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 18,088

発行済株式数

54,328,049

配当利回り

0.14 (5.79%)

PER

12.97

1 株当たり利益 (EPS)

0.18

歳入

93.27M

純利益

10.44M

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products thro... Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Mascot, Australia. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

vitalifesciences.com

本社

Mascot, Australia

設立

2026

Vita Life Sciences Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker VLS. The last closing price for Vita Life Sciences was AUD2.40. Over the last year, Vita Life Sciences shares have traded in a share price range of AUD 1.88 to AUD 2.84.

Vita Life Sciences currently has 54,328,049 shares in issue. The market capitalisation of Vita Life Sciences is AUD133.10 million. Vita Life Sciences has a price to earnings ratio (PE ratio) of 12.97.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.02	0.82304526749	2.43	2.56	2.38	10072	2.45952324	DE
4	-0.08	-3.16205533597	2.53	2.56	2.35	18907	2.45834956	DE
12	-0.08	-3.16205533597	2.53	2.62	2.35	17902	2.50894416	DE
26	0.02	0.82304526749	2.43	2.84	2.27	16336	2.53053105	DE
52	0.56	29.6296296296	1.89	2.84	1.88	15123	2.44715765	DE
156	0.87	55.0632911392	1.58	2.84	1.42	14988	2.10918554	DE
260	1.23	100.819672131	1.22	2.84	1.04	17244	1.88149686	DE

VLS - Frequently Asked Questions (FAQ)

What is the current Vita Life Sciences Limited share price?

The current share price of Vita Life Sciences Limited is AUD 2.45

How many Vita Life Sciences Limited shares are in issue?

Vita Life Sciences Limited has 54,328,049 shares in issue

What is the market cap of Vita Life Sciences Limited?

The market capitalisation of Vita Life Sciences Limited is AUD 133.1M

What is the 1 year trading range for Vita Life Sciences Limited share price?

Vita Life Sciences Limited has traded in the range of AUD 1.88 to AUD 2.84 during the past year

What is the PE ratio of Vita Life Sciences Limited?

The price to earnings ratio of Vita Life Sciences Limited is 12.97

What is the cash to sales ratio of Vita Life Sciences Limited?

The cash to sales ratio of Vita Life Sciences Limited is 1.39

What is the registered address of Vita Life Sciences Limited?

The registered address for Vita Life Sciences Limited is 1-5 Chalmers Crescent, Mascot, New South Wales, 2020

What is the Vita Life Sciences Limited website address?

The website address for Vita Life Sciences Limited is vitalifesciences.com

Which industry sector does Vita Life Sciences Limited operate in?

Vita Life Sciences Limited operates in the Pharmaceuticals sector

manibiotech

manibiotech 3分前

Give it a break Gary

You have been saying non stop that Eden was and is needed for UK approval . So why not apply to FDA to begin with if manufacturing at scale was needed either way .

double_m

double_m 3分前

Sissy, based on everything we know, an RM is more of a 'when' than an 'if.' What "insiders" know or don't know WRT a merger doesn't move this SP. Retail investors aren't privy to that info. It NEEDS volume and it's your guess as anyone's here why there isn't any especially after what we've seen ov

glenn1919

glenn1919 3分前

NEXR................................https://stockcharts.com/sc3/ui/?s=NEXR&p=W&b=5&g=0&id=p86431144783

Chartmaster

Chartmaster 3分前

It's getting punched in the gut! Down to .01 she goes!

TheKid5

TheKid5 4分前

I am optomistic, but not everybody is.
https://ohiorivervalleyinstitute.org/financially-risky-chemical-recycling-facility-would-burden-west-virginians/

creakyhottie

creakyhottie 4分前

Another poster on X My comment: although I think the company already has Ukraine connections

GONDAS
@TB_MS_I
·
1h
Translated from Korean
$ONDS

$ONDS
@CeoOndas
This is news that they gave a keynote

JJ24

Get some consistent volume and we off

NASDAQ2020

NASDAQ2020 4分前

Our Merger & Acquisition partner is working on finding us a suitor. If an acceptable offer is presented today, we’ll be more than happy to consider it. But if not, we will wait another quarter or two to show realistic revenues and profits that include Lisdex and show the trending for the sales of Li

Trooperstocks

Trooperstocks 5分前

$NCRA Nocera, Inc. recently announced its strategic transformation into Nocera Holdings, expanding its corporate focus into artificial intelligence, data centers, robotics, biotech, and blockchain.
In a filing dated May 2026, Nocera (NCRA) secures $100M equity line and amends note funding use

Trooperstocks

Trooperstocks 5分前

$NCRA Nocera, Inc. recently announced its strategic transformation into Nocera Holdings, expanding its corporate focus into artificial intelligence, data centers, robotics, biotech, and blockchain.
In a filing dated May 2026, Nocera (NCRA) secures $100M equity line and amends note funding use

NASDAQ2020

NASDAQ2020 5分前

Insiders Hoarding Shares !!!!!!!!!!!!!! For THE Buyout !!!!!!!!!!!!

https://www.secform4.com/insider-holders/1053369.html#:~:text=Insider%20Holders%20&%20Insider%20Ownership%20%2D%20ELITE%20PHARMACEUTICALS%20INC%20(ELTP),not%20adjusted%20for%20stock%20split.
Bullish

work-n-hard

work-n-hard 6分前

Jumped back out for now. The shorts were too strong and the chart is not in shareholders favor IMHO.
Just glad I wasn't heavy.

hayward

hayward 7分前

Crazy as usual from a high of 14.94 down to 14.41 on 10,000 shares never ending games WTF

Michael

9Coastal

9Coastal 7分前

(See previous posts first)

Information regarding "No-Action Relief:

No-action" relief requests are typically used when a company asks the SEC staff to confirm they will not recommend enforcement action if the company proceeds with a specific, unconventional transaction

DrHigh

but how would that directly benefit Toucan. dont be selfish. when in doubt think about what you can do on a daily basis for your favorite private equity

12yearplan

12yearplan 7分前

Runner, who's MJ?..

fredscott36

fredscott36 8分前

edit +98.49 .....CORRELATION IS NOT CAUSATION.............(in the law, but in life, logically)............

.......how----MF--ing------ever..........correlation is ......IS......causation....80% of the time, statistically..............................

........to me, on F

Seminole Red

Seminole Red 8分前

smally....+11 F.....

CharlesNet

CharlesNet 9分前

MRJ25

Pulte has not abandoned the FHFA. He is still director of FHFA.
Nothing has been officially said about him leaving FHFA.

Helter Skelter

Helter Skelter 9分前

😺 I asked AI...

Doesn't $BB's QNX RTOS Safety in Nvidia's THOR platform qualify BlackBerry as a FOUNDATIONAL player DESERVING of RE-RATING by Wall Street?

BlackBerry’s ($BB) integration of its QNX real-time opera

doinit

been trying,,these posts keep applauding him

Trooperstocks

Trooperstocks 10分前

$NCRA Nocera Announces Strategic Transformation into Nocera Holdings, Expanding Across Artificial Intelligence, Data Centers, Robotics, Biotech and Digital Assets; Company Expands Strategic Vision Following Amendment of up to $300 Million Facility to Pursue Acquisitions, Partnerships and Investments

BlazingStocks

BlazingStocks 10分前

$EVTV With approximately 11 MW identified, hardware ordered for an initial 6 MW deployment, and discussions involving up to 500 MW of additional capacity, the scale of the vision continues to expand. ⚡🏗️

Vita Life Sciences

Carel Industries

Neuberger Energy Infrast...

Premier Development and ... (ID)

Dividend Strength Portfo...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。